Published in Curr Probl Cardiol on January 01, 2013
The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease. Genome Res (2013) 1.10
Campylobacter jejuni-associated perimyocarditis: two case reports and review of the literature. BMC Infect Dis (2016) 0.92
Complexities in the relationship between infection and autoimmunity. Curr Allergy Asthma Rep (2014) 0.90
Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation. J Cardiovasc Transl Res (2014) 0.88
Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance. ISRN Radiol (2014) 0.86
Y genetic variation and phenotypic diversity in health and disease. Biol Sex Differ (2015) 0.84
Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond Engl) (2015) 0.82
The role of sex differences in autophagy in the heart during coxsackievirus B3-induced myocarditis. J Cardiovasc Transl Res (2013) 0.81
Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol (2015) 0.80
CAP2 in cardiac conduction, sudden cardiac death and eye development. Sci Rep (2015) 0.76
Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight (2016) 0.75
Nano-scale treatment for a macro-scale disease: nanoparticle-delivered siRNA silences CCR2 and treats myocarditis. Eur Heart J (2014) 0.75
Acute myocardial infarction or acute myocarditis? Discharge registry-based study of likelihood and associated features in hospitalised patients. BMJ Open (2015) 0.75
Unresolved issues in theories of autoimmune disease using myocarditis as a framework. J Theor Biol (2014) 0.75
Biomarker and more: can translocator protein 18 kDa predict recovery from brain injury and myocarditis? Biomark Med (2014) 0.75
Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment. Biomed Res Int (2016) 0.75
A Risk Prediction Model for In-hospital Mortality in Patients with Suspected Myocarditis. Chin Med J (Engl) (2017) 0.75
Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort. Pediatr Cardiol (2017) 0.75
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med (1996) 12.77
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med (2004) 12.52
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med (1997) 10.68
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med (2001) 9.75
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
Idiopathic dilated cardiomyopathy. N Engl J Med (1994) 7.74
Myocarditis. N Engl J Med (2009) 7.12
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med (2001) 7.05
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 6.58
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell (2007) 5.85
Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med (2002) 5.74
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med (2004) 4.72
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09
The complex role of estrogens in inflammation. Endocr Rev (2007) 4.07
Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975. JAMA (1976) 3.94
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Viral myocarditis. A review. Am J Pathol (1980) 3.33
The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. J Heart Lung Transplant (2011) 3.01
Adult heart disease due to the Coxsackie virus B infection. Medicine (Baltimore) (1968) 2.96
Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J (2007) 2.76
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA (2007) 2.75
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation (2004) 2.73
Gender differences and aging: effects on the human heart. J Am Coll Cardiol (1995) 2.49
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation (2010) 2.45
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation (2010) 2.41
Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol (2002) 2.33
Myocarditis. Lancet (2011) 2.21
Low serum testosterone and increased mortality in men with coronary heart disease. Heart (2010) 2.14
Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 2.13
Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol (2011) 2.10
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.08
Myocarditis. Prog Cardiovasc Dis (2010) 2.00
Sex differences in autoimmune disease from a pathological perspective. Am J Pathol (2008) 1.94
Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm (2010) 1.94
Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol (2003) 1.91
Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J (2009) 1.86
Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clin Proc (2007) 1.84
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation (2006) 1.78
Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail (2009) 1.78
Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation (2002) 1.74
Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73
The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences. Eur Heart J (2009) 1.73
Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. The Italian Multicenter Cardiomyopathy Study Group (SPIC) Am J Cardiol (1993) 1.69
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol (2003) 1.67
Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation (2010) 1.67
Carditis in poliomyelitis; an anatomic study of 35 cases and review of the literature. Am J Pathol (1949) 1.64
Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol (1994) 1.64
Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol (2007) 1.61
Sexual dimorphism of humoral immunity with human vaccines. Vaccine (2008) 1.56
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol (2000) 1.54
Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail (2009) 1.53
Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods (2007) 1.53
Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy. J Am Coll Cardiol (2005) 1.48
Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest (2001) 1.45
Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J (2005) 1.39
IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol (2003) 1.39
Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol (2009) 1.39
Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med (2009) 1.38
Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol (1997) 1.38
Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation (2012) 1.34
Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol (2000) 1.31
The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol (1920) 1.31
Sexually dimorphic gene expression in the heart of mice and men. J Mol Med (Berl) (2007) 1.30
Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab (2010) 1.29
Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun (2008) 1.27
Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J (1986) 1.25
Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev (2010) 1.24
Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am J Pathol (1987) 1.22
Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology (2011) 1.20
Quality of life in patients with heart failure: do gender differences exist? Heart Lung (2001) 1.20
Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovasc Genet (2011) 1.19
Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J (2006) 1.19
Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res (2009) 1.18
Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res (2006) 1.14
Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol (1989) 1.13
Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med Care (1998) 1.13
Familial occurrence of postpartal heart failure. Arch Intern Med (1963) 1.11
Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res (2001) 1.10
Gender differences in left ventricular growth. Hypertension (1995) 1.10
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Update on myocarditis. J Am Coll Cardiol (2012) 3.12
Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med (2009) 2.81
Myocarditis. Lancet (2011) 2.21
Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol (2011) 2.10
Myocarditis. Prog Cardiovasc Dis (2010) 2.00
Cardiac sarcoidosis. Am Heart J (2008) 1.89
Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med (2003) 1.71
Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res (2008) 1.67
Diagnosis and treatment of viral myocarditis. Mayo Clin Proc (2009) 1.65
The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol (2012) 1.63
Noninvasive imaging in myocarditis. J Am Coll Cardiol (2006) 1.62
Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet (2003) 1.58
Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol (2006) 1.48
The management of myocarditis. Eur Heart J (2011) 1.43
Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation (2012) 1.42
A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol (2003) 1.42
Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am J Pathol (2008) 1.41
Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun (2008) 1.27
Cardiac calcified amorphous tumor in a patient presenting for ventricular tachycardia ablation: intracardiac echocardiogram diagnosis and management. J Interv Card Electrophysiol (2009) 1.24
The natural history of recurrent optic neuritis. Arch Neurol (2004) 1.22
Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg (2006) 1.22
Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol (2004) 1.22
Early identification of cardiovascular risk using genomics and proteomics. Nat Rev Cardiol (2010) 1.14
Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Brain Res (2006) 1.14
Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.11
Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol Med (2004) 1.11
Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc (2013) 1.11
The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J Card Fail (2002) 1.09
Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. J Am Coll Cardiol (2012) 1.08
Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev (2013) 1.05
Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. J Mol Cell Cardiol (2002) 1.04
Type 1 diabetes: virus infection or autoimmune disease? Nat Immunol (2002) 1.00
Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am J Physiol Heart Circ Physiol (2012) 1.00
Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice. Circulation (2004) 0.97
Diagnosis and management of peripartum cardiomyopathy. Heart (2011) 0.97
Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol (2011) 0.94
Median arcuate ligament syndrome: a nonvascular, vascular diagnosis. Vasc Endovascular Surg (2011) 0.92
Complexities in the relationship between infection and autoimmunity. Curr Allergy Asthma Rep (2014) 0.90
Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity (2008) 0.90
Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol (2009) 0.88
Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study. Arthritis Res Ther (2009) 0.88
Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation. J Cardiovasc Transl Res (2014) 0.88
Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A. J Immunol (2013) 0.88
IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circ Heart Fail (2012) 0.88
Speckle tracking echocardiography in acute myocarditis. Int J Cardiovasc Imaging (2012) 0.87
Response to alemtuzumab in FIP1L1/PDGFRA-negative hypereosinophilic myocarditis on serial cardiac magnetic resonance imaging. J Am Coll Cardiol (2012) 0.87
Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy. J Card Fail (2012) 0.87
Pathogenesis and diagnosis of myocarditis. Heart (2012) 0.86
Total lymphoid irradiation: new therapeutic option for refractory giant cell myocarditis. J Heart Lung Transplant (2004) 0.85
Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy. Int J Cardiol (2007) 0.85
Low-dose inorganic mercury increases severity and frequency of chronic coxsackievirus-induced autoimmune myocarditis in mice. Toxicol Sci (2011) 0.84
Autoimmune myocarditis, valvulitis, and cardiomyopathy. Curr Protoc Immunol (2013) 0.83
Management of myopericarditis. Expert Rev Cardiovasc Ther (2013) 0.83
We see only what we look for: imaging cardiac inflammation. Circ Cardiovasc Imaging (2013) 0.82
Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol (2007) 0.82
TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4. Am J Physiol Regul Integr Comp Physiol (2012) 0.82
Sex differences in a murine model of Sjögren's syndrome. Ann N Y Acad Sci (2009) 0.82
Sex and race/ethnicity reporting in clinical trials: a necessity, not an option. J Womens Health (Larchmt) (2011) 0.81
When should high-grade heart block trigger a search for a treatable cardiomyopathy? Circ Arrhythm Electrophysiol (2011) 0.81
Peripheral arterial disease: diagnosis and management. Mayo Clin Proc (2008) 0.81
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication. J Vasc Surg (2011) 0.80
Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol (2012) 0.80
Right from the heart: when should myocardial biopsy be performed for suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia? Eur Heart J (2008) 0.80
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation (2016) 0.80
Viral infection, inflammation, and the risk of idiopathic dilated cardiomyopathy: can the fire be extinguished? Am J Cardiol (2002) 0.79
The heat is off: immunosuppression for myocarditis revisited. Eur Heart J (2009) 0.78
Transplantation for myocarditis: a controversy revisited. J Heart Lung Transplant (2005) 0.78
Antimicrobial agents for myocarditis: target the pathway, not the pathogen. Heart (2009) 0.78
Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease. J Vasc Surg (2013) 0.78
Giant cell myocarditis: clinical and pathological features in an Indian population. Cardiovasc Pathol (2012) 0.77
Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniques. J Clin Apher (2007) 0.77
Transcutaneous partial pressure of oxygen after surgical wounds. Vasc Med (2004) 0.77
The role of autoimmunity in thromboangiitis obliterans (Buerger's disease). Ann N Y Acad Sci (2013) 0.76
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Trials (2011) 0.76
Beraprost for the treatment of intermittent claudication. J Am Coll Cardiol (2003) 0.75
Biomarker and more: can translocator protein 18 kDa predict recovery from brain injury and myocarditis? Biomark Med (2014) 0.75
Getting to the heart of the matter: cardiac involvement in transthyretin-related amyloidosis. Eur Heart J (2012) 0.75
Recent clinical and translational research on pediatric myocarditis. Prog Pediatr Cardiol (2011) 0.75
Low-dose mercury heightens early innate response to coxsackievirus infection in female mice. Inflamm Res (2014) 0.75
Cautious interpretation of data regarding myopericarditis associated with smallpox vaccination. J Am Coll Cardiol (2005) 0.75
Infectious etiologies of chronic diseases: focus on women. Emerg Infect Dis (2004) 0.75
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. J Am Coll Cardiol (2007) 0.75
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Circulation (2007) 0.75
Echocardiographic features of atrial myocarditis with giant cells: a case report. J Am Soc Echocardiogr (2004) 0.75
Use of intermittent pneumatic compression for treatment of upper extremity vascular ulcers. Angiology (2005) 0.75
ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force III: prevention and control of cardiovascular complications of emerging infectious diseases and potential biological terrorism agents and diseases. J Am Coll Cardiol (2007) 0.75